Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Pharming Group N.V. - Filing #1883078

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Disclosure of effect of changes in foreign exchange rates [text block]	—	—	—	Currency risk	—	—	—	—	—	—	—	—
Disclosure of information when currency is not exchangeable into another currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [text block]	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets	148,297,000 USD	—	—	—	—	—	147,871,000 USD	—	—	—	—	—
Current assets	277,500,000 USD	—	—	—	—	—	249,444,000 USD	—	—	—	—	—
Non-current liabilities	161,461,000 USD	—	—	—	—	—	157,628,000 USD	—	—	—	—	—
Current liabilities	59,698,000 USD	—	—	—	—	—	46,771,000 USD	—	—	—	—	—
Revenue	—	—	—	205,622,000 USD	—	—	—	—	—	—	198,871,000 USD	—
Profit (loss)	—	— USD	— USD	13,674,000 USD	— USD	13,674,000 USD	—	— USD	— USD	— USD	15,996,000 USD	15,996,000 USD
Other comprehensive income	—	— USD	11,054,000 USD	11,054,000 USD	— USD	— USD	—	— USD	17,085,000 USD	— USD	17,085,000 USD	— USD
Comprehensive income	—	— USD	11,054,000 USD	2,620,000 USD	— USD	13,674,000 USD	—	— USD	17,085,000 USD	— USD	1,089,000 USD	15,996,000 USD